Skip to content

Imaging genetics in Autism Spectrum Disorders

Imaging genetics in Autism Spectrum Disorders - ImaGenASD

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON35266
Enrollment
600
Registered
2008-02-12
Start date
2008-05-19
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

autism ASD

Interventions

None listed

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
2 Years to 99 Years

Inclusion criteria

Inclusion criteria: General Inclusion criteria 1) Aged at least 6 years ;Inclusion criteria for subjects with ASD 1) DSM-IV (APA, 1994) diagnosis in the autism spectrum;Inclusion criteria for controls 1) no DSM-IV (APA, 1994) diagnosis 2) no scores in the clinical range on the Child Behavior Checklist (CBCL) and Teacher Rating Form (TRF) 3) IQ > 70

Exclusion criteria

Exclusion criteria: 1) major illness of the cardiovascular, the endocrine, the pulmonal or the gastrointestinal system 2) presence of metal objects in or around the body (pacemaker, dental braces) 3) history of or present neurological disorder 4) for individuals over 12 years of age: legal incompetence, defined as the obvious inability to comprehend the information that is presented by the investigator and is outlined in the Information letter and on which the decision to participate in the study is to be based

Design outcomes

Primary

MeasureTime frame
The primary outcome measures will be genotype on autism risk genes and measures of brain structure, such as volume, gray and white matter density and white matter integrity.

Secondary

MeasureTime frame
Secondary outcome measures will be the results form questionnaires, interview and psychological assessment.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)